X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs NATCO PHARMA - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. NATCO PHARMA WOCKHARDT LTD./
NATCO PHARMA
 
P/E (TTM) x -22.6 16.2 - View Chart
P/BV x 2.3 17.4 13.2% View Chart
Dividend Yield % 0.0 0.7 0.3%  

Financials

 WOCKHARDT LTD.   NATCO PHARMA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-18
NATCO PHARMA
Mar-14
WOCKHARDT LTD./
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,012877 115.4%   
Low Rs532424 125.5%   
Sales per share (Unadj.) Rs355.9223.4 159.3%  
Earnings per share (Unadj.) Rs-60.331.1 -194.0%  
Cash flow per share (Unadj.) Rs-46.840.3 -116.1%  
Dividends per share (Unadj.) Rs0.015.00 0.2%  
Dividend yield (eoy) %00.8 0.2%  
Book value per share (Unadj.) Rs257.8219.5 117.5%  
Shares outstanding (eoy) m110.6333.07 334.5%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x2.22.9 74.5%   
Avg P/E ratio x-12.820.9 -61.2%  
P/CF ratio (eoy) x-16.516.1 -102.2%  
Price / Book Value ratio x3.03.0 101.0%  
Dividend payout %016.1 -0.1%   
Avg Mkt Cap Rs m85,37921,504 397.0%   
No. of employees `0006.3NA-   
Total wages/salary Rs m9,3711,128 830.9%   
Avg. sales/employee Rs Th6,295.0NM-  
Avg. wages/employee Rs Th1,498.3NM-  
Avg. net profit/employee Rs Th-1,066.3NM-  
INCOME DATA
Net Sales Rs m39,3697,389 532.8%  
Other income Rs m1,202167 719.5%   
Total revenues Rs m40,5717,556 536.9%   
Gross profit Rs m181,793 1.0%  
Depreciation Rs m1,495304 491.2%   
Interest Rs m2,555366 697.7%   
Profit before tax Rs m-2,8301,290 -219.4%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257309 83.3%   
Profit after tax Rs m-6,6691,027 -649.1%  
Gross profit margin %024.3 0.2%  
Effective tax rate %-9.123.9 -37.9%   
Net profit margin %-16.913.9 -121.8%  
BALANCE SHEET DATA
Current assets Rs m33,7963,681 918.0%   
Current liabilities Rs m26,9173,123 862.0%   
Net working cap to sales %17.57.6 231.1%  
Current ratio x1.31.2 106.5%  
Inventory Days Days7989 88.7%  
Debtors Days Days8959 152.1%  
Net fixed assets Rs m39,6647,685 516.1%   
Share capital Rs m553331 167.3%   
"Free" reserves Rs m27,9686,670 419.3%   
Net worth Rs m28,5227,259 392.9%   
Long term debt Rs m21,731955 2,275.7%   
Total assets Rs m81,62011,957 682.6%  
Interest coverage x-0.14.5 -2.4%   
Debt to equity ratio x0.80.1 579.2%  
Sales to assets ratio x0.50.6 78.1%   
Return on assets %-5.011.7 -43.2%  
Return on equity %-23.414.2 -165.2%  
Return on capital %-7.720.7 -37.0%  
Exports to sales %039.4 0.0%   
Imports to sales %05.7 0.0%   
Exports (fob) Rs mNA2,908 0.0%   
Imports (cif) Rs mNA421 0.0%   
Fx inflow Rs m9,8073,445 284.6%   
Fx outflow Rs m1,789703 254.5%   
Net fx Rs m8,0192,743 292.4%   
CASH FLOW
From Operations Rs m6841,440 47.5%  
From Investments Rs m6,302-1,089 -578.6%  
From Financial Activity Rs m-7,695-353 2,181.7%  
Net Cashflow Rs m-664-1 44,563.8%  

Share Holding

Indian Promoters % 74.5 52.0 143.2%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 2.3 7.8 29.3%  
FIIs % 7.7 16.6 46.3%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 26.0 59.2%  
Shareholders   67,757 25,395 266.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   PFIZER  ABBOTT INDIA  PLETHICO PHARMA  WYETH LTD  GSK PHARMA  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Metal & Realty Stocks Gain(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.2% while the Hang Seng is down 1%.

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Should You Buy These Mouthwatering High Dividend Stocks?(Profit Hunter)

Aug 1, 2018

Many stocks are yielding dividends even upwards of 4%-5%. Here are the kinds you should pick, and the ones to avoid.

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

NFO - Axis Equity Hybrid Fund: A Worthy Proposition?(Outside View)

Aug 1, 2018

PersonalFN explains if NFO: Axis Equity Hybrid Fund, would be a worthy proposition currently.

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 14, 2018 12:13 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS